Biological PsA: Retrospective observational study on anti-IL17 treatment patterns in the management of psoriatic arthritis. LIL-IXE-2020-01 (LY2439821)
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: LILLY, SA
- Execution start: 06/10/2020
- End of execution: 30/01/2021
- PI: ENRIQUE RAYA ALVAREZ